HVO vs. PRTC, OXB, FARN, HZD, VRP, ARIX, AVCT, CIR, 4BB, and BVXP
Should you be buying hVIVO stock or one of its competitors? The main competitors of hVIVO include PureTech Health (PRTC), Oxford Biomedica (OXB), Faron Pharmaceuticals Oy (FARN), Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), Arix Bioscience (ARIX), Avacta Group (AVCT), Circassia Group (CIR), 4basebio (4BB), and Bioventix (BVXP). These companies are all part of the "biotechnology" industry.
hVIVO vs.
hVIVO (LON:HVO) and PureTech Health (LON:PRTC) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment, community ranking and earnings.
34.9% of hVIVO shares are owned by institutional investors. Comparatively, 79.9% of PureTech Health shares are owned by institutional investors. 14.0% of hVIVO shares are owned by company insiders. Comparatively, 15.9% of PureTech Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
hVIVO has higher revenue and earnings than PureTech Health. PureTech Health is trading at a lower price-to-earnings ratio than hVIVO, indicating that it is currently the more affordable of the two stocks.
hVIVO has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500. Comparatively, PureTech Health has a beta of 1.02, indicating that its share price is 2% more volatile than the S&P 500.
hVIVO has a net margin of 25.96% compared to PureTech Health's net margin of -17,620.94%. hVIVO's return on equity of 47.93% beat PureTech Health's return on equity.
PureTech Health has a consensus target price of GBX 455, suggesting a potential upside of 266.94%. Given PureTech Health's higher probable upside, analysts plainly believe PureTech Health is more favorable than hVIVO.
PureTech Health received 406 more outperform votes than hVIVO when rated by MarketBeat users. Likewise, 86.60% of users gave PureTech Health an outperform vote while only 70.06% of users gave hVIVO an outperform vote.
In the previous week, PureTech Health had 4 more articles in the media than hVIVO. MarketBeat recorded 5 mentions for PureTech Health and 1 mentions for hVIVO. hVIVO's average media sentiment score of 0.75 beat PureTech Health's score of 0.54 indicating that hVIVO is being referred to more favorably in the media.
Summary
hVIVO and PureTech Health tied by winning 8 of the 16 factors compared between the two stocks.
Get hVIVO News Delivered to You Automatically
Sign up to receive the latest news and ratings for HVO and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (LON:HVO) was last updated on 4/24/2025 by MarketBeat.com Staff
Buy HVO Stock Free HVO Stock Alerts